the pharma and biotech world converges on Basel for the Drug Discovery Innovation Programme (DDIP) Europe 2026 — two days of ideas, people, and opportunities you won't find anywhere else.

September 29–30, 2026

Mövenpick Hotel Basel, Switzerland If you haven't secured your seat yet, here's why this is the one to be at. Audience Snapshot


  1. 120+ Senior Leaders
  2. 40+ Industry Speakers
  3. 20+ Sponsors & Exhibitors
  4. 80% Pharma / Biotech
  5. 12+ Networking Hours
  6. 60+ 1:1 Meetings


Who's Taking the Stage This year's programme brings together senior leaders from some of the biggest names in the industry:


  1. Soroush Safaei Safaei Senior Principal Scientist — Sanofi (Conference Chairperson)
  2. Manda Pasarkar, DTM , Global Regulatory Affairs CMC Head — Sanofi
  3. Stefan Schiesser , Director of Medicinal Chemistry — AstraZeneca
  4. Vijay Chandrasekar , Associate Principal Scientist — AstraZeneca
  5. Dave Drodge , Group Lead, Digital Transformation AI & Digital Marketing — Roche
  6. Heena Khatter, PhD r, Principal Scientist — Roche
  7. Elizaveta Solovyeva , Associate Director & Sr. Principal Data Scientist — Novartis Biomedical Research
  8. Dr Dragan Urosevic , Senior Global Program Medical Director — Novartis


Plus 20+ additional speakers from AI-driven biotechs, CROs, and academic institutions including Ryvu Therapeutics, Insilico Medicine, University Hospital Basel, and University of Bern. Together, they'll be sharing real, practical insight on target discovery, translational science, medicinal chemistry, and where drug development is headed next. What Past Attendees Say

"The event was a fantastic and remarkable showcase of knowledge and innovation. I was truly impressed by the diversity of topics and the excellence of the presentations." — Weill Cornell Medicine

"Everyone has done an excellent job inviting speakers from various fields within drug discovery. The talks are well-diversified, which is especially beneficial for me and our company." — Biolexis Therapeutics, Inc. "

A focused conference with insights across the drug discovery process, from chemistry to manufacturing to cell viability prediction. Thanks to the DDIP team for such a comprehensive event!" — Serna.Bio

Why Attend


  1. Direct access to decision-makers from Sanofi, AstraZeneca, Roche, and Novartis
  2. Two days of focused, high-level discussion — no filler
  3. A rare chance to build relationships with peers tackling the same challenges you are


Don't Miss It With just 14 days left, now's the time to lock in your place.

Get the Attendee List — see who's already confirmed

Book Now— secure your pass